Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gsk Plc (GSK.LN)

Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gsk Plc 980 Great West Road Brentford Middlesex TW8 9GS GBR

https://www.gsk.com P: 208-047-5000 F: 208-047-7807

Description:

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Key Statistics

Overview:

Market Capitalization, $K 53,189,314
Shares Outstanding, K 4,080,500
Annual Sales, $ 30,328 M
Annual Net Income, $ 4,928 M
Last Quarter Sales, $ 8,012 M
Last Quarter Net Income, $ -58,000 K
% of Insider Shareholders 0.20%
% of Institutional Shareholders 56.95%

Growth:

1-Year Return -7.61%
3-Year Return -31.16%
5-Year Return -40.71%
5-Year Revenue Growth -0.32%
5-Year Earnings Growth 5.64%
5-Year Dividend Growth -11.03%

Per-Share Information:

Most Recent Earnings -0.01 on 10/30/24
Next Earnings Date N/A
Earnings Per Share ttm 0.61
EPS Growth vs. Prev Year -56.54%
Annual Dividend Rate, $ 0.60
Annual Dividend Yield 4.60%
Most Recent Dividend 0.150 on 11/14/24
Next Ex-Dividends Date 11/14/24
Dividend Payable Date 01/09/25
Dividend Payout Ratio 98.85%
Most Recent Split 4-5 on 07/19/22

GSK.LN Ratios

Ratio
Price/Earnings ttm 21.47
Price/Earnings forward 7.20
Return-on-Equity % 18.50%
Return-on-Assets % 4.22%
Profit Margin % 16.25%
Debt/Equity 1.14
Price/Sales 1.72
Price/Book 3.80
Book Value/Share 3.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar